Where does Orthofix S.R.L. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Orthofix S.R.L. ranks #7,750 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Orthofix S.R.L. hold?

Orthofix S.R.L. holds 42 US utility patents granted between 2015 and 2025, spanning 6 technology areas.

What is Orthofix S.R.L.'s Innovation Score?

Orthofix S.R.L. has an Innovation Score of 40.6 out of 100 (top 35% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Orthofix S.R.L. focus on?

Orthofix S.R.L.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 40 patents, ranking #480 of 7,127 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is Orthofix S.R.L.'s patent grant rate increasing or decreasing?

Orthofix S.R.L.'s recent grant velocity is +100% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Orthofix S.R.L.'s patents?

Orthofix S.R.L.'s patents average 14.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Orthofix S.R.L. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Orthofix S.R.L.

USPTO PatentsView assignee record - 42 granted patents across 6 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Orthofix ranks #7,750 of 49,997 tracked US assignees by granted-patent volume, with 42 patents across 6 technology areas.

#7,750
of 49,997 US assignees by volume: Top 35%
by Innovation Score (40.6/100): 14.9
avg claims per patent: +100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7750 · Foreign Corporation #7,750 · 42 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 42 grants
UPPER-Q #7,750/49,997
PHOTO-FINISH Nogra Pharma
CPC-NARROW A61B · 6 areas
INNOV-PAR 40.6/100
CLAIMS-RICH 14.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nogra Pharma Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Orthofix’s 40.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.0 pts (32%) Velocity 10.0 pts (25%) Breadth 8.7 pts (21%) Claim depth 8.9 pts (22%)

Qualcomm Incorporated · highest

85
Cardiovascular Systems · near

41
GTJ Ventures · near

41
Orthofix S R L · this assignee

41
Pixart Imaging… · near

41
Teledyne Dalsa B V · near

41
3D Lighting… · lowest

7

What this shows Orthofix's Innovation Score is 40.6/100 (top 35% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Orthofix?

Each dot is one of Orthofix’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Orthofix’s own 14.9 claims/patent is at or below the 16.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Orthofix vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Orthofix's grants concentrate

Orthofix S.R.L. is a focused PatentsView assignee: 6 CPC subclasses with 95.2% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2018 (6 grants) versus a trough of 1 in 2015. By volume, Orthofix sits between Nogra Pharma Limited and Peraso Technologies Inc..

Orthofix's three-year grant acceleration

Orthofix S.R.L. shows 15 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Nogra Pharma

42
Northwestern Poly…

42
Osaka Prefecture…

42
Orbotech

42
Ortronics

42
Ouraring

42
Overstock com

42
Peraso

42
Orthofix S R L ◀

42

What this shows Orthofix holds 42 patents at rank #7,750, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Orthofix

By rank, the assignees closest to #7,750 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Orthofix's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Orthofix, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Orthofix ranks #480 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (41 here).

Pixart Imaging (PENANG) SDN. BHD. 41 Teledyne Dalsa B.V. 41 Cardiovascular Systems, Inc. 41 GTJ Ventures, LLC 41

Orthofix's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 35% higher than 65% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Orthofix S.R.L. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	2.4%
2016	2	4.8%
2017	2	4.8%
2018	6	14.3%
2019	1	2.4%
2020	5	11.9%
2021	4	9.5%
2022	3	7.1%
2023	6	14.3%
2024	6	14.3%
2025partial year	6	14.3%

Which technologies does Orthofix S.R.L. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 40

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 2

F16B - Devices FOR Fastening OR Securing Constructional Elements OR Machine Parts Together, e.g. Nails, Bolts, Circlips, Clamps, Clips OR WEDGES; Joints OR Jointing 1

A61H - Physical Therapy Apparatus, e.g. Devices FOR Locating OR Stimulating Reflex Points IN THE BODY; Artificial RESPIRATION; MASSAGE; Bathing Devices FOR Special Therapeutic OR Hygienic Purposes OR Specific Parts OF THE Body 1

H10N - Electric Solid-state Devices NOT Otherwise Provided FOR 1

Y10T - Technical Subjects Covered BY Former US Classification 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Orthofix S.R.L.'s patent record in context - here's where to go next.

Orthofix S.R.L.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 95.2% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #7,750 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Orthofix S.R.L. against Nogra Pharma Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.